Reversing concepts on COPD irreversibility

Soriano J. B., Mannino D. M.

Source: Eur Respir J 2008; 31: 695-696
Journal Issue: April
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Soriano J. B., Mannino D. M.. Reversing concepts on COPD irreversibility. Eur Respir J 2008; 31: 695-696

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology
Source: ERS Satellites 2021
Year: 2021

Rethinking COPD Exacerbations: a global patient perspective
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021


Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008


Translating mechanisms to new drugs for COPD exacerbations
Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD”
Year: 2009


Dissecting COPD exacerbations: time to rethink our definition
Source: Eur Respir J, 50 (3) 1701432; 10.1183/13993003.01432-2017
Year: 2017



Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020

Accelerated ageing in COPD
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018


AATD: Implications for our understanding of usual COPD
Source: Annual Congress 2013 –Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description
Year: 2013


Defining “stable chronic hypercapnia” in patients with COPD: the physiological perspective
Source: Eur Respir J, 55 (2) 1902172; 10.1183/13993003.02172-2019
Year: 2020



Defining “stable chronic hypercapnia” in patients with COPD: the physiological perspective
Source: Eur Respir J, 55 (2) 1902365; 10.1183/13993003.02365-2019
Year: 2020



Challenges in COPD exacerbations and future research and unknowns
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013

Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities
Source: Eur Respir J 2014; 43: 662-664
Year: 2014


What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Possible mechanisms underlying the development of cachexia in COPD
Source: Eur Respir J 2008; 31: 492-501
Year: 2008



Are COPD and cardiovascular disease fundamentally intertwined?
Source: Eur Respir J 2016; 47:1307-1309
Year: 2016


Some aspects of COPD ethiopathogenesis
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009

Reversibility at pulmonary function tests: can it have implications in patients with COPD?
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021